The Exchange had sought clarification from RPG Life Sciences Limited for the quarter ended 31-Dec-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Financial results submitted is not as per format prescribed under Schedule III of the Companies Act. -2. 2013 or as per Indian Accounting Standard. The response of the Company is enclosed.
RPGLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The NSE asked RPG Life Sciences to explain why its financial results for the quarter ending 31 December 2025 did not follow the format required under Schedule III of the Companies Act and Indian Accounting Standards. This was raised under Regulation 33 of SEBI's Listing Obligations and Disclosure Requirements. The company has submitted its response to the exchange, which is enclosed with the filing. The matter relates to the presentation format of the results rather than any dispute over the underlying numbers themselves.
This appears to be a routine procedural compliance query on how the results were formatted, not a reflection of weak financials or a regulatory penalty. Investors should wait to see if the company's response triggers any further exchange action, but at this stage there is no direct negative implication for shareholders.